Keywords: avi, biopharma, starts, pivotal, trial, avicine, following

AVI Biopharma starts pivotal trial of Avicine

Article | 24 December 1999

Print This

Following a successful Phase II program and discussions with the US Foodand Drug Administration, AVI Biopharma has decided to proceed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in